Downregulation of CIITA function by protein kinase A (PKA)-mediated phosphorylation: Mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines

Molecular and Cellular Biology

Volumn 21, Issue 14, 2001, Pages 4626-4635

  Li, G ^a   Harton, J A ^a   Zsu, X ^a   Ting, J P Y ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASS II TRANSACTIVATOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PROSTAGLANDIN E; SERINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ALPROSTADIL; ANIMALS; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; DOWN-REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICE; MONOCYTES; NUCLEAR PROTEINS; PHOSPHOAMINO ACIDS; PHOSPHORYLATION; TRANS-ACTIVATORS;

ANIMALIA;

EID: 0034948954     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.14.4626-4635.2001     Document Type: Article

References (65)

1. Induction of HLA class II genes by IFN-gamma is transcriptional and requires a trans-acting protein
2. Tumor-induced modulation of macrophage class II MHC molecule mRNA expression
3. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon
4. The I kappa B proteins: Multifunctional regulators of Rel/nf-kappa B transcription factors
5. Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells
6. Hyperphosphorylation and increased proteolytic breakdown of c-Myb induced by the inhibition of Ser/Thr protein phosphatases
7. Efficient repression of endogenous major histocompatibility complex class II expression through dominant-negative CIITA mutants isolated by a functional selection strategy
8. Regulation of transcription of MHC class II genes
9. Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: Identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor
10. Human major histocompatibility complex class II-associated invariant chain gene promoter. Functional analysis and in vivo protein/DNA interactions of constitutive and IFN-gamma-induced expression
11. IFN-gamma induces islet cell MHC antigens and enhances autoimmune streptozotocin-induced diabetes in the mouse
12. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes
13. Endosomal proteolysis and MHC class II function
14. Association of STATs with relatives and friends
15. Importance of acidic, proline/ serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: Generation of transdominant-negative mutants
16. Phosphorylated CREB binds specifically to the nuclear protein CBP
17. STATs and gene regulation
18. Transcription factor activity of STAT proteins: Structural requirements and regulation by phosphorylation and interacting proteins
19. Associations and interactions between bare lymphocyte syndrome factors
20. Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells
21. Activation of the cAMP cascade inhibits an early event involved in murine macrophage Ia expression
22. The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32
23. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes
24. Regulation of class II MHC gene expression by interferons: Insights into the mechanism of action of interferon
25. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation
26. GTP binding by class II transactivator: Role in nuclear import
27. Class II transactivator: Mastering the art of major histocompatibility complex expression
28. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo
29. Inhibition of IFN-gamma induction of class II MHC genes by cAMP and prostaglandins
30. Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements
31. Evidence that IFN-c does not affect MHC class II gene expression at the posttranscriptional level in a mouse macrophage cell line
32. Transcriptional regulation of the transforming growth factor-beta2 promoter by cAMP-responsive element-binding protein (CREB) and activating transcription factor-1(ATF-1) is modulated by protein kinases and the coactivators p300 and CREB-binding protein
33. Roles of phosphorylation sites in regulating activity of the transcription factor Pho4
34. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator
35. Nuclear protein CBP is a coactivator for the transcription factor CREB
36. Mediators of inflammation
37. Two distinct domains within CIITA mediate self-association: Involvement of the GTP-binding and leucine-rich repeat domains
38. Evidence for retinoblastoma protein (RB) dependent and independent IFN-gamma responses: RB coordinately rescues IFN-gamma induction of MHC class II gene transcription in noninducible breast carcinoma cells
39. Regulation of MHC class II genes: Lessons from a disease
40. Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein
41. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex
42. The role of MHC class II molecules in susceptibility and resistance to autoimmunity
43. CREB regulates MHC class II expression in a CIITA-dependent manner
44. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA
45. Induction of MHC class II antigens on bovine cells of nonlymphoid origin by recombinant bovine interferon-gamma and tumor necrosis factor-alpha
46. Quantitative control of MHC class II expression by the transactivator CIITA
47. Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism
48. Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression
49. Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene
50. MHC class II restricted antigen presentation
51. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta
52. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene
53. Class II MHC transcriptional mutants are defective in higher order complex formation
54. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA)
55. Prostaglandins and thromboxanes
56. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5
57. A novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-gamma
58. MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300
59. Corticosteroids inhibit murine macrophage la expression and interleukin 1 production
60. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA
61. HIV-1 Tat mutants in the cysteine-rich region downregulate HLA class II expression in T lymphocytic and macrophage cell lines
62. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines
63. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency
64. A transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II MHC promoter
65. Effect of prostaglandin E2 on the gamma-interferon induction of antigen-presenting ability in P388D1 cells and on IL-2 production by T-cell hybridomas